WithdrawnNot Applicable

The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

Stopped: recruiting problems

0Started 2010-09

Plain-language summary

The involvement of eukaryotic translation initiation factor 4E (eIF4E) in human placental implantation and in the pathological pregnancies: preeclampsia and IUGR.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * post TOP or DELIVERY Exclusion Criteria: \-

What they're measuring

measure the Translation Initiation effect of experimental variables observational studies

Timeframe: 2 years

Trial details

NCT IDNCT01179542

SponsorMeir Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-10

View on ClinicalTrials.gov More Pregnancy trials